Lisa Charisa Wijaya
Business Development Analyst | Business Development - Jr Manager at Morula IVF Indonesia (PT. Morula Indonesia)- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Morula IVF Indonesia (PT. Morula Indonesia)
-
Indonesia
-
Hospitals and Health Care
-
200 - 300 Employee
-
Business Development Analyst | Business Development - Jr Manager
-
Sep 2022 - Present
- Explore new market opportunities for the company through branch expansion and product development. - Conduct feasibility study & give recommendations on the development / improvement / discontinuation of company's products & services. - Create strategic partnership, including JV opportunities with domestic & international partner to increase company's revenue & valuation. - Explore new market opportunities for the company through branch expansion and product development. - Conduct feasibility study & give recommendations on the development / improvement / discontinuation of company's products & services. - Create strategic partnership, including JV opportunities with domestic & international partner to increase company's revenue & valuation.
-
-
-
-
Business Development and Licensing Officer
-
Jan 2022 - Sep 2022
KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel biologics and select biosimilars in oncology and high-specialty therapeutic areas (typically pre-IND or early clinical stage), with the objective to out-license them in target geographies after finishing clinical development as well as regulatory and reimbursement approvals. Platforms of interest currently include Fc-fusion proteins, antibodies, bispecifics, ADCs, cell therapies and therapeutic vaccines. The company is backed by Asian pharma companies Kalbe (market cap US$5.5 billion) and Genexine (market cap US$1.3 billion) and US private equity giant General Atlantic (AUM US$ 78 billion) Show less
-
-
-
PT Kalbe Farma, Tbk
-
Indonesia
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
-
Feb 2019 - Jan 2022
Managing company strategic product portfolio, as well as to find and execute strategic partnership with global companies through in- & out- licensing. Responsible in developing business opportunities in biologic products (novel therapeutics & biosimilar), cell therapy and molecular diagnostic to overseas & locally.
-
-
-
Jan 2017 - Feb 2019
Joined management trainee program with 2 years of intense class training from IPMI International Business School (curriculum covering basic finance, idea & feasibility generation, business & marketing plan) in parallel of on-the-job training. During this term, I was assigned to support Kalbe International division in order to expand Kalbe Farma's existing business to Asia and Africa territories. Executed product management with overseas team for products ranging from prescription drugs, food supplement and medical nutrition. Experienced in developing strategic portfolio for nutraceutical business in pharmaceutical division and new formula for medical nutrition products, as well as creating strategic partnership with global companies. Show less
-
-
-
PT HM Sampoerna Tbk.
-
Indonesia
-
Tobacco Manufacturing
-
700 & Above Employee
-
Internship
-
Sep 2015 - Oct 2015
Product Development Department (interest: Flavor division) Responsible for a new project: measuring and analyzing the concentration of humectant substances in several brands of tobacco. Successfully present the result to Head of PD, managers & seniors. Comprehend to use GC-MS and HPLC. Product Development Department (interest: Flavor division) Responsible for a new project: measuring and analyzing the concentration of humectant substances in several brands of tobacco. Successfully present the result to Head of PD, managers & seniors. Comprehend to use GC-MS and HPLC.
-
-
Education
-
Universitas Pelita Harapan (UPH)
Gelar Sarjana, Bioteknologi